Bloomberg BusinessweekBloomberg Businessweek

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

View descriptionShare

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan. 

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Businessweek

    5,072 clip(s)

Bloomberg Businessweek

Carol Massar and Tim Stenovec bring you reporting from the magazine that helps global leaders stay a 
Social links
Follow podcast
Recent clips
Browse 5,073 clip(s)